Searchable abstracts of presentations at key conferences on calcified tissues

ba0002op3 | (1) | ICCBH2013

Calcimimetics as adjunct therapy in XLH: 18 months experience

Alon Uri , Haney Connie

Objective: Based on our preliminary findings, indicating a potential for Cinacalcet (due to its suppression of PTH (CJASN 2008 3 658)), to allow the use of lower doses of oral phosphate (OP) and calcitriol in treating XLH, the objective of this study was to examine its long-term effect as adjunct treatment in children with XLH.Methods: Eight children (F5), ages 7.8–20.9 years (median 13.9), who were already treated by OP an...

ba0004p37 | (1) | ICCBH2015

Teriparatide following bisphosphonates in the treatment of osteoporosis in post-pubertal teenagers

Alon Uri , Monachino Penny

Background: Treatment of osteoporosis with bisphosphonates may result in severe suppression of bone turnover leading to adynamic bone disease. Teriparatide is now commonly used as an anabolic agent in adults with osteoporosis, and has the potential to reverse the effect of bisphosphonates. However its use in pediatrics is restricted to those with closed growth plates and information regarding its effect in this age group limited.Objective: To study the e...

ba0004p38 | (1) | ICCBH2015

Serum 25-vitamin D level is lower in African American compared to Caucasian children

Srivastava Tarak , Sebestyen Judith , Alon Uri

Background and Objective: Serum 25-Vitamin D level (S-VitD) was recently reported to be significantly lower in African American (AA) adults compared with their Caucasian (CS) counterparts, despite having a higher bone mineral density, due to lower serum vitamin D-binding protein (NEJM 2013; 369: 1991). The objective of this study was to examine if this observation holds true in Hispanic and AA children.Material and methods: The database of clinical labor...